Summary & Overview
HCPCS G2024: SARS-CoV-2 Specimen Collection in SNF or HHA
HCPCS Level II code G2024 represents specimen collection for SARS-CoV-2 testing performed in a skilled nursing facility (SNF) or collected by a laboratory on behalf of a home health agency (HHA). This code captures a specific non-procedural service tied to COVID-19 diagnosis confirmation and surveillance among high-risk, congregate, and homebound populations. Nationally, accurate coding for specimen collection supports public health surveillance, facilitates reimbursement for testing workflows, and clarifies billing responsibilities between facilities, laboratories, and agencies.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical and operational context, how the service is typically delivered, and the implications for billing workflows. The publication also provides benchmarking and policy context where available, including common modifiers and typical sites of service, and notes when input data elements are not provided.
This summary is intended for billing managers, compliance officers, laboratory administrators, and clinicians who need a concise reference on HCPCS Level II code G2024, its clinical purpose, and the payer landscape relevant to specimen collection for SARS-CoV-2 in SNF and HHA settings.
Billing Code Overview
HCPCS Level II code G2024 describes specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) from an individual in a skilled nursing facility (SNF) or collected by a laboratory on behalf of a home health agency (HHA). The description indicates the service applies to specimen collection for SARS-CoV-2 testing and is not limited by specimen source (any specimen source).
Service Type: Specimen collection for SARS-CoV-2 testing
Typical Site of Service: Skilled Nursing Facility (SNF) or collection performed by a laboratory on behalf of a Home Health Agency (HHA)
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is a resident of a skilled nursing facility (SNF) who develops fever and new cough during a COVID-19 outbreak. The SNF nurse notifies the facility’s medical director and arranges for a specimen collection for SARS-CoV-2. A trained phlebotomist or respiratory specimen collector employed by a reference laboratory visits the SNF, dons appropriate PPE, and collects a nasopharyngeal or other approved specimen (e.g., nasal swab, saliva) from the resident. The specimen is labeled with the resident’s identifiers and clinical information, packaged per biosafety guidelines, and sent to the laboratory for molecular testing. Documentation in the resident’s chart includes the indication for testing (symptoms or exposure), time and date of collection, specimen source, collector name and credentials, and tracking/chain-of-custody information. When testing is ordered by a home health agency on behalf of a homebound patient, a laboratory may perform specimen collection at the patient’s residence following similar workflow and documentation practices.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Office or other outpatient service, normal | When specimen collection is part of a routine outpatient encounter and professional service is furnished as usual. |
22 | Increased procedural services | When collection required substantially greater effort (e.g., combative patient, multiple attempts) documented in record. |
23 | Unusual anesthesia | Not typically used for respiratory swab; used only if unusual anesthesia required for collection. |
26 | Professional component | When reporting only the professional component separate from technical services by a laboratory. |
52 | Reduced services | When specimen collection was partially reduced or limited compared to the full procedure. |
53 | Discontinued procedure | If collection was attempted but discontinued before completion for documented clinical reasons. |
54 | Surgical care only | Rarely applicable; used only if billing professional provided only surgical care unrelated to specimen collection. |
55 | Postoperative management only | Not typically applicable to this procedure; included when only postoperative care is billed. |
56 | Preoperative management only | Not typically applicable; used if only preoperative management is billed. |
62 | Two surgeons | Not routinely applicable; used only if two qualified providers performed the collection collaboratively in an unusual situation. |
QK | Medical direction of two, three, or four assistants | Applicable when a physician directs allied health professionals assisting with collection under specified supervision rules. |
QX | Qualified nonphysician practitioner | When a qualified nonphysician practitioner (e.g., nurse practitioner) performs the specimen collection under their independent scope. |
QY | Service furnished by a physician organization | When services are furnished by a physician organization billing under applicable rules. |
TC | Technical component | When billing only the laboratory technical component of testing-related services, separate from professional interpretation. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 363L00000X | Diagnostic Laboratory | Laboratories performing specimen collection and testing for SARS-CoV-2. |
| 173B00000X | Nursing — Skilled Nursing Facility | SNF nursing staff who coordinate collection and facilitate access for laboratory collectors. |
| 182100000X | Nurse Practitioner | Nurse practitioners who may order and/or perform specimen collection in home or SNF settings. |
| 207Q00000X | Family Medicine | Primary care physicians who order testing for SNF or home health patients. |
| 207L00000X | Internal Medicine | Internists and hospitalists coordinating testing for symptomatic or exposed patients. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
J12.82 | Pneumonia due to coronavirus disease 2019 | Symptomatic respiratory infection prompting SARS-CoV-2 specimen collection. |
U07.1 | COVID-19 | Primary diagnosis for which SARS-CoV-2 testing is performed. |
R05 | Cough | Common symptom leading to testing for SARS-CoV-2. |
R50.9 | Fever, unspecified | Fever in a SNF resident commonly triggers SARS-CoV-2 testing. |
Z20.828 | Contact with and (suspected) exposure to other viral communicable diseases | Documented exposure in a facility or household that leads to specimen collection. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
87426 | Infectious agent antigen detection by immunoassay technique, multiple step method; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (e.g., COVID-19), amplified probe technique | Laboratory test frequently performed on specimens collected for SARS-CoV-2 diagnosis; follows specimen collection. |
87635 | Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), amplified probe technique, multiple types or subtypes; multiplex | Molecular PCR testing commonly performed on collected specimens for definitive diagnosis. |
87804 | Infectious agent antigen detection by immunoassay with direct optical observation; antigen; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19) | Point-of-care antigen testing that may be performed on-site after specimen collection. |
99000 | Handling and/or conveyance of specimen for transfer from the physician's office to a laboratory | Ancillary service sometimes billed when specimens are collected and transported to an outside laboratory. |